Ocular Therapeutix, Inc. announced the appointment of Steve Meyers as Chief Commercial Officer. Mr. Meyers has over 20 years of commercial experience, including several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets. Mr. Meyers served in other commercial capacities at leading biotechnology organizations including Regeneron, AbbVie, and Procter & Gamble.

Prior to joining Ocular, Mr. Meyers served as Vice President of Sales at Flexion Therapeutics in the orthopedic space. Mr. Meyers holds a B.S. from Louisiana State University in Cardiopulmonary Science.